Informational profileWatchlist
Mazdutide
A dual GLP-1 and glucagon receptor agonist; regulatory status varies by jurisdiction.
Also known as IBI362
What it interacts with
A target relationship describes a research mechanism, not a proven personal outcome.
How far the research has gone
Clinical studies ongoing
Developer: Innovent Biologics
Status as of: 2026-09-22
Scope: United States trial record; approval not assessed here
Structure provenance
Conceptual visualization only
We have not added a verified sequence or experimental coordinate set for this record. The orbital graphic represents mapped target systems, not the molecule's physical 3D shape. No synthetic molecular model is presented as measured data.
Compare by target
Nearby signals
This profile is informational. Inclusion does not mean OnimaChain sells this molecule or that a regulator has approved it. Development status can change and should be checked against the linked primary source.